Literature DB >> 19472087

Bilateral breast cancer in a survivor of acute lymphoblastic leukemia: a case report.

Umut Demirci1, Fatma Buğdayci, Asli Cakir, Bahar Gürlek, Ipek Işik Gönül, Süleyman Büyükberber, Mustafa Benekli, Uğur Coşkun.   

Abstract

Although breast cancer is the most common disease for women, bilateral breast cancer is a rare situation. Development of a second malignancy which is the most frightening side effect, may be related with genetic predisposition or cancer treatment. Because our case is a survivor of acute lymphoblastic leukemia, development of bilateral breast cancer which occurs rarely in early ages, is discussed with the help of literature.

Entities:  

Mesh:

Year:  2009        PMID: 19472087     DOI: 10.1007/s12032-009-9238-4

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  20 in total

Review 1.  Late effects of cancer and its treatment.

Authors:  P A Ganz
Journal:  Semin Oncol Nurs       Date:  2001-11       Impact factor: 2.315

2.  Clonal isolation of different strains of mouse mammary tumor virus-like DNA sequences from both the breast tumors and non-Hodgkin's lymphomas of individual patients diagnosed with both malignancies.

Authors:  Polly R Etkind; Alexandre F R Stewart; Thambi Dorai; Daniel J Purcell; Peter H Wiernik
Journal:  Clin Cancer Res       Date:  2004-09-01       Impact factor: 12.531

3.  Is mouse mammary tumor virus an etiologic agent of human breast cancer and lymphoma?

Authors:  Peter H Wiernik; Polly R Etkind
Journal:  South Med J       Date:  2006-02       Impact factor: 0.954

4.  Protein accumulation and gene mutation of p53 in bilateral breast cancer. South-East Sweden Breast Cancer Group.

Authors:  M Stenmark-Askmalm; M Gentile; S Wingren; O Ståhl
Journal:  Acta Oncol       Date:  2001       Impact factor: 4.089

5.  Molecular cloning and characterization of mouse mammary tumor proviruses from a T-cell lymphoma.

Authors:  J P Dudley; A Arfsten; C L Hsu; C Kozak; R Risser
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

6.  Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood.

Authors:  Anja Borgmann; Christina Zinn; Reinhard Hartmann; Ralf Herold; Peter Kaatsch; Gabriele Escherich; Anja Möricke; Günter Henze; Arend von Stackelberg
Journal:  Eur J Cancer       Date:  2007-11-05       Impact factor: 9.162

7.  Second malignant neoplasms after cancer in childhood or adolescence. Nordic Society of Paediatric Haematology and Oncology Association of the Nordic Cancer Registries.

Authors:  J H Olsen; S Garwicz; H Hertz; G Jonmundsson; F Langmark; M Lanning; S O Lie; P J Moe; T Møller; R Sankila
Journal:  BMJ       Date:  1993-10-23

8.  Second malignancies after chemotherapy and radiotherapy for Hodgkin disease.

Authors:  Gregory M Chronowski; Richard B Wilder; Larry B Levy; Edward N Atkinson; Chul S Ha; Fredrick B Hagemeister; Ibrahim Barista; Maria A Rodriguez; Andreas H Sarris; Mark A Hess; Fernando Cabanillas; James D Cox
Journal:  Am J Clin Oncol       Date:  2004-02       Impact factor: 2.339

9.  Bilateral primary breast cancer: a prospective study of disease incidence.

Authors:  M A Chaudary; R R Millis; E O Hoskins; M Halder; R D Bulbrook; J Cuzick; J L Hayward
Journal:  Br J Surg       Date:  1984-09       Impact factor: 6.939

10.  Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958-1996: a search for common mechanisms.

Authors:  C Dong; K Hemminki
Journal:  Br J Cancer       Date:  2001-09-28       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.